Last reviewed · How we verify

midazolam and lidocaine

Amany Ahmed Eissa · Phase 1 active Small molecule

midazolam and lidocaine is a Small molecule drug developed by Amany Ahmed Eissa. It is currently in Phase 1 development.

At a glance

Generic namemidazolam and lidocaine
SponsorAmany Ahmed Eissa
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about midazolam and lidocaine

What is midazolam and lidocaine?

midazolam and lidocaine is a Small molecule drug developed by Amany Ahmed Eissa.

Who makes midazolam and lidocaine?

midazolam and lidocaine is developed by Amany Ahmed Eissa (see full Amany Ahmed Eissa pipeline at /company/amany-ahmed-eissa).

What development phase is midazolam and lidocaine in?

midazolam and lidocaine is in Phase 1.

Related